Lou Pillai and Ehsan Ehsani
Advertisement
Lou Pillai is the founder of Ulivmo and most recently, he was the Head of Data and Digital at Immunomedics (acquired by Gilead).
Ehsan Ehsani is a director of consulting at CGI and leader of commercial launch and M&A services within the healthcare and life sciences sector.
Articles by Lou Pillai and Ehsan Ehsani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma
4
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
5